Found: 27
Select item for more details and to access through your institution.
Hepatitis C Virus Reinfection Among People Who Inject Drugs: Long-Term Follow-Up of the HERO Study.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 8, p. e2430024, doi. 10.1001/jamanetworkopen.2024.30024
- By:
- Publication type:
- Article
Distrust in the Health Care System and Adherence to Direct-Acting Antiviral Therapy among People with Hepatitis C Virus Who Inject Drugs.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 8, p. 1304, doi. 10.3390/v16081304
- By:
- Publication type:
- Article
Reduction in Depressive Symptoms in People who Inject Drugs who Are Cured of Hepatitis C Virus Infection: The HERO Study.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 11, p. 1, doi. 10.1093/ofid/ofad498
- By:
- Publication type:
- Article
Changes in Health-related Quality of Life for Hepatitis C Virus–Infected People Who Inject Drugs While on Opioid Agonist Treatment Following Sustained Virologic Response.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 9, p. 1586, doi. 10.1093/cid/ciab669
- By:
- Publication type:
- Article
Hepatitis C Virus Direct-Acting Antiviral Treatment Adherence Patterns and Sustained Viral Response Among People Who Inject Drugs Treated in Opioid Agonist Therapy Programs.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 11, p. 2093, doi. 10.1093/cid/ciab334
- By:
- Publication type:
- Article
Low Hepatitis C Reinfection Following Direct-acting Antiviral Therapy Among People Who Inject Drugs on Opioid Agonist Therapy.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 12, p. 2695, doi. 10.1093/cid/ciz693
- By:
- Publication type:
- Article
Cost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment Programs.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 7, p. 1397, doi. 10.1093/cid/ciz384
- By:
- Publication type:
- Article
Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study.
- Published in:
- BMC Infectious Diseases, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12879-024-09124-3
- By:
- Publication type:
- Article
Integrated Screening for Tuberculosis and HIV in Tuberculosis Contact Investigations: Lessons Learned in North Carolina.
- Published in:
- Public Health Reports, 2014, v. 129, p. 21, doi. 10.1177/00333549141291S104
- By:
- Publication type:
- Article
Hepatitis C Resistance-Associated Substitutions Among People Who Inject Drugs Treated With Direct-Acting Antiviral-Containing Regimens.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 10, p. 1, doi. 10.1093/ofid/ofab474
- By:
- Publication type:
- Article
Low Adherence Achieves High HCV Cure Rates Among People Who Inject Drugs Treated With Direct-Acting Antiviral Agents.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 10, p. 1, doi. 10.1093/ofid/ofaa377
- By:
- Publication type:
- Article
Declines in Depressive Symptoms Among People who Inject Drugs Treated With Direct-Acting Antivirals While on Opioid Agonist Therapy.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 10, p. 1, doi. 10.1093/ofid/ofaa380
- By:
- Publication type:
- Article
Current management options for latent tuberculosis: a review.
- Published in:
- Infection & Drug Resistance, 2012, v. 5, n. 2, p. 163, doi. 10.2147/IDR.S29180
- By:
- Publication type:
- Article
More intensive hepatitis C virus care models promote adherence among people who inject drugs with active drug use: The PREVAIL study.
- Published in:
- Journal of Viral Hepatitis, 2023, v. 30, n. 2, p. 172, doi. 10.1111/jvh.13756
- By:
- Publication type:
- Article
Changes in alcohol use during hepatitis C treatment in persons who inject drugs.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 11, p. 1004, doi. 10.1111/jvh.13737
- By:
- Publication type:
- Article
Alcohol and Drug Use Surrounding Sex Among Men Who Have Sex with Men in India.
- Published in:
- Sexuality & Culture, 2021, v. 25, n. 4, p. 1383, doi. 10.1007/s12119-021-09814-z
- By:
- Publication type:
- Article
Health Care Utilization in HIV-Infected Patients: Assessing the Burden of Hepatitis C Virus Coinfection.
- Published in:
- AIDS Patient Care & STDs, 2012, v. 26, n. 9, p. 541, doi. 10.1089/apc.2012.0170
- By:
- Publication type:
- Article
Geographic Information System-based Screening for TB, HIV, and Syphilis (GIS-THIS): A Cross-Sectional Study.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0046029
- By:
- Publication type:
- Article
Barriers to Using Text Message Appointment Reminders in an HIV Clinic.
- Published in:
- Telemedicine & e-Health, 2014, v. 20, n. 1, p. 86, doi. 10.1089/tmj.2012.0275
- By:
- Publication type:
- Article
Community-based HCV screening: knowledge and attitudes in a high risk urban population.
- Published in:
- BMC Infectious Diseases, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2334-14-74
- By:
- Publication type:
- Article
Community-based HCV screening: knowledge and attitudes in a high risk urban population.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study.
- Published in:
- Annals of Internal Medicine, 2022, v. 175, n. 9, p. 1221, doi. 10.7326/M21-4119
- By:
- Publication type:
- Article
Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy: A Randomized Controlled Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Considerations for the Design of Pre-exposure Prophylaxis (PrEP) Interventions for Women: Lessons Learned from the Implementation of a Novel PrEP Intervention.
- Published in:
- AIDS & Behavior, 2021, v. 25, n. 12, p. 3987, doi. 10.1007/s10461-021-03353-2
- By:
- Publication type:
- Article
A Pilot Study to Evaluate a Novel Pre-exposure Prophylaxis Peer Outreach and Navigation Intervention for Women at High Risk for HIV Infection.
- Published in:
- AIDS & Behavior, 2021, v. 25, n. 5, p. 1411, doi. 10.1007/s10461-020-02979-y
- By:
- Publication type:
- Article
Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: secondary analysis of the PREVAIL randomized clinical trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article